Literature DB >> 18938145

The controversial place of vitamin C in cancer treatment.

J Verrax1, P Buc Calderon.   

Abstract

In 2008, we celebrate the 80th anniversary of the discovery of vitamin C. Since then, we know that vitamin C possesses few pharmacological actions although it is still perceived by the public as a "miracle-pill" capable to heal a variety of illnesses. Cancer is one of the most common diseases for which a beneficial role of vitamin C has been claimed. Thus, its dietary use has been proposed in cancer prevention for several years. Apart from this nutritional aspect, an extensive and often confusing literature exists about the use of vitamin C in cancer that has considerably discredited its use. Nevertheless, recent pharmacokinetic data suggest that pharmacologic concentrations of vitamin C can be achieved by intravenous injections. Since these concentrations exhibit anticancer activities in vitro, this raises the controversial question of the re-evaluation of vitamin C in cancer treatment. Therefore, the purpose of this commentary is to make a critical review of our current knowledge of vitamin C, focusing on the rationale that could support its use in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18938145     DOI: 10.1016/j.bcp.2008.09.024

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  24 in total

1.  Effects of ascorbic acid and β-carotene on HepG2 human hepatocellular carcinoma cell line.

Authors:  Erkan Yurtcu; Ozlem Darcansoy Iseri; Feride I Sahin
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

2.  The history of vitamin C research in India.

Authors:  I B Chatterjee
Journal:  J Biosci       Date:  2009-06       Impact factor: 1.826

Review 3.  A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon.

Authors:  Ines Batinic-Haberle; Zrinka Rajic; Ludmil Benov
Journal:  Anticancer Agents Med Chem       Date:  2011-05-01       Impact factor: 2.505

4.  Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.

Authors:  Satya S Pathi; Ping Lei; Sandeep Sreevalsan; Gayathri Chadalapaka; Indira Jutooru; Stephen Safe
Journal:  Nutr Cancer       Date:  2011-09-15       Impact factor: 2.900

5.  Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells.

Authors:  Hidenobu Fukumura; Motohiko Sato; Kyouhei Kezuka; Itaru Sato; Xianfeng Feng; Satoshi Okumura; Takayuki Fujita; Utako Yokoyama; Haruki Eguchi; Yoshihiro Ishikawa; Tomoyuki Saito
Journal:  J Physiol Sci       Date:  2012-03-06       Impact factor: 2.781

Review 6.  Oxidative stress resistance in Deinococcus radiodurans.

Authors:  Dea Slade; Miroslav Radman
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

7.  Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors.

Authors:  Stephen T Keir; Mark W Dewhirst; John P Kirkpatrick; Darell D Bigner; Ines Batinic-Haberle
Journal:  Anticancer Agents Med Chem       Date:  2011-02       Impact factor: 2.505

Review 8.  Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries.

Authors:  Mark Levine; Sebastian J Padayatty; Michael Graham Espey
Journal:  Adv Nutr       Date:  2011-03-10       Impact factor: 8.701

9.  Vitamin C in synergism with cisplatin induces cell death in cervical cancer cells through altered redox cycling and p53 upregulation.

Authors:  Ankita Leekha; Bahadur S Gurjar; Aakriti Tyagi; Moshahid A Rizvi; Anita K Verma
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-09       Impact factor: 4.553

10.  In Vitro and In Silico Analysis of Ascorbic Acid Towards Lanosterol 14-α-Demethylase Enzyme of Fluconazole-Resistant Candida albicans.

Authors:  Arumugam Ganeshkumar; Suvaiyarasan Suvaithenamudhan; Rajendran Rajaram
Journal:  Curr Microbiol       Date:  2020-11-10       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.